Trials / Conditions / Endometrial Dedifferentiated Carcinoma
Endometrial Dedifferentiated Carcinoma
4 registered clinical trials studyying Endometrial Dedifferentiated Carcinoma — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Se NCT05256225 | National Cancer Institute (NCI) | Phase 3 |
| Recruiting | Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial NCT05112601 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel a NCT03914612 | National Cancer Institute (NCI) | Phase 3 |
| Recruiting | Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial NCT05049538 | M.D. Anderson Cancer Center | — |